Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
JAMA|June 10, 1988
Characterization of recombinant DNA derived-human luteinizing hormone in vitro and in vivo. Efficacy in ovulation induction and corpus luteum supportJ A Simon, D R Danforth, J S Hutchison, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1994
Recombinant human follicle-stimulating hormone stimulates multiple follicular growth, but minimal estrogen production in gonadotropin-releasing hormone antagonist-treated monkeys: examining the role of luteinizing hormone in follicular development and steroidogenesisV J Karnitis, D H Townson, C I Friedman, et al.
Contraception|August 1, 1989
Contraceptive potential of RU 486 by ovulation inhibition: III. Preliminary observations on once weekly oral administrationD R Danforth, C Dubois, A Ulmann, et al.
Endocrinology|April 1, 1991
Inhibition of pituitary gonadotropin secretion by the gonadotropin-releasing hormone antagonist antide. II. Development of an in vitro bioassay for characterization of pharmacokinetics and pharmacodynamics of antide in circulationD R Danforth, R F Williams, K Gordon, et al.
The Journal of Clinical Endocrinology and Metabolism|December 1, 1988
Prolonged duration of gonadotropin inhibition by a third generation GnRH antagonistJ A Leal, R F Williams, D R Danforth, et al.
Microbiology (Reading, England)|May 13, 2022
The serotype a-EmaA adhesin of Aggregatibacter actinomycetemcomitans does not require O-PS synthesis for collagen binding activityGaoyan G Tang-Siegel, David R Danforth, Jake Tristano, et al.
Contraception|August 1, 1990
Single dose long-term suppression of testosterone secretion by a gonadotropin-releasing hormone antagonist (Antide) in male monkeysM C Edelstein, K Gordon, R F Williams, et al.
Contraception|August 1, 1989
Contraceptive potential of RU 486 by ovulation inhibition: II. Suppression of pituitary gonadotropin secretion in vitroJ P Wolf, D R Danforth, A Ulmann, et al.
The Journal of Clinical Endocrinology and Metabolism|February 1, 1990
Extended presence of antide (Nal-Lys GnRH antagonist) in circulation: prolonged duration of gonadotropin inhibition may derive from antide binding to serum proteinsD R Danforth, K Gordon, J A Leal, et al.
Contraception|April 1, 1992
GnRH antagonists suppress prolactin release in non-human primatesK Gordon, R F Williams, D R Danforth, et al.
Pageof 7